Entero Healthcare Solutions Ltd (ENTERO)

NSE · Consumer Discretionary · Consumer Services · Retailing · Pharmacy Retail

₹1,575.20

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹1,575.20 on 30 Oct 2026. The share price traded between ₹944.00 and ₹1,920.00 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹1,575.20

Low ₹944.00High ₹1,920.00

Market cap₹6,856 crorelast close × shares
P/E54.6on reported profit, last four quarters
Profit, last 12 months₹125 crto shareholders
Profit incl. minorities₹168 crlast 12 months
Return on equity6.9%year to Mar 2026
EBITDA margin4.0%year to Mar 2026
Debt to equity0.40year to Mar 2026
Net margin2.2%year to Mar 2026
Dividend yieldnonelast 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
-2,00002,0004,0006,0008,000
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue2,5223,3003,9225,0966,591
Net profit-29-1140107146
EBITDA margin1.0%1.9%2.9%3.4%4.0%
Borrowings9741,101338385677

₹ crore. Over three years, compounded: revenue grew 25.9% a year.

Recent filings

Questions about Entero Healthcare Solutions Ltd

What is Entero Healthcare Solutions Ltd's market value?

Entero Healthcare Solutions Ltd's market value is ₹6,856 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 54.6, the last close over earnings per share for the last four reported quarters.

When are Entero Healthcare Solutions Ltd's next results?

Entero Healthcare Solutions Ltd's next results are listed for 4 Nov 2026 (the exchange's notice: Financial Results/Other business matters). Dates are as the company announced them, on the list of 30 Oct 2026.

Who are Entero Healthcare Solutions Ltd's largest named shareholders?

In the shareholding pattern for the quarter ended 30 Sep 2026, the largest named holders above 1% were: Orbimed Asia III Mauritius Limited (promoter group) 38%; Prabhat Agrawal (promoter group) 9.26%; Prem Sethi (promoter group) 5.15%. Percentages are of all shares.

Go further with ENTERO

Free to start: test a trading idea on ENTERO's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmacy Retail), by market value.

Same sector

The largest companies in the wider sector (Consumer Discretionary), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

P/E 54.6 is the close over earnings per share, the profit that belongs to the company's shareholders (market cap divided by P/E: 125 crore for the last 12 months, shown above). The net profit including the share owned by minority shareholders of subsidiaries is 168 crore; market cap divided by that gives 40.8. The last 12 months are the four latest reported quarters, so their profit can differ from the newest year's in the table below.